Released on = April 10, 2007, 2:20 am

Press Release Author = Namrata

Industry = Small Business

Press Release Summary = Today early stage partnering is a core component of both
biotech and pharmaceutical business strategy, allowing companies to access promising
new and emerging compounds and technologies.

Press Release Body = Early Stage and Discovery Deals: Strategy, Structure and
Payment Terms
Today early stage partnering is a core component of both biotech and pharmaceutical
business strategy, allowing companies to access promising new and emerging compounds
and technologies. To become a successful player within the life science industry it
is crucial to understand the changing dynamics of the industry's early stage
dealmaking trends. Dealmaking in the pharmaceutical industry is constantly growing;
big pharmaceutical companies are forecast to receive around 40-50% of their revenue
from in-licensed products by 2010. The balance of dealmaking activity has also
moved, from the later stages of development to the early stages, where deals have
not only increased in number but value too. For example in 2006 ChemoCentryx signed
a potential US$1.5 billion drug discovery and development deal with GlaxoSmithKline.
Deal complexity is advancing in terms of both financial reward structures and
exchange of non-monetary capabilities. Therefore, to obtain a more rounded
understanding of valuation and to achieve the maximum benefits of a deal it is
essential to consider non-monetary benefits as well as deal values.

For more information kindly visit
http://www.bharatbook.com/general/Early_Stage_and_Discovery_Deals_Strategy_Structure_and_Payment_Terms.html


Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium,
Sector 11, Plot No.57,
PO Box.54, CBD Belapur,
Navi Mumbai - 400 614, India.
maharashtra
Phone: +91-(022)-2757 8668 / 2757 9438
Fax: +91-(022)-2757 9131
E-mail: info@bharatbook.com